Sirolimus and mycophenolate mofetil as calcineurin inhibitor–free immunosuppression in a cardiac transplant patient with chronic renal failure

2004 ◽  
Vol 23 (6) ◽  
pp. 770-773 ◽  
Author(s):  
Jan Groetzner ◽  
Ingo Kaczmarek ◽  
Bruno Meiser ◽  
Markus Müller ◽  
Sabine Daebritz ◽  
...  
Keyword(s):  
Renal Failure ◽  
Mycophenolate Mofetil ◽  
Chronic Renal Failure ◽  
Calcineurin Inhibitor ◽  
Transplant Patient ◽  
Cardiac Transplant ◽  
Cardiac Transplant Patient

Removal of Foscarnet by Hemodialysis using Dialysate-Side Values

2000 ◽  
Vol 23 (3) ◽  
pp. 165-167 ◽  
Author(s):  
R. Sam ◽  
S.B. Patel ◽  
A. Popli ◽  
D.J. Leehey ◽  
J.G. Gambertoglio ◽  
...  
Keyword(s):  
Renal Failure ◽  
Acute Renal Failure ◽  
Transplant Patient ◽  
Antiviral Agent ◽  
Cardiac Transplant ◽  
Cmv Infection ◽  
Cardiac Transplant Patient

Foscarnet is an antiviral agent widely used in the treatment of cytomegalovirus (CMV) infection. We describe a cardiac transplant patient, who while being maintained with hemodialysis because of tobramycin-induced acute renal failure, was given Foscarnet for disseminated CMV infection. Using dialysate-side clearance methodology, we found the dialyzer clearance of Foscarnet to be in the order of 89 ml/min. (Int J Artif Organs 2000; 23: 165–7)

Portal venous gas in a cardiac transplant patient.

1996 ◽  
Vol 166 (4) ◽  
pp. 992-993 ◽  
Author(s):  
H T Ozgur ◽  
E C Unger ◽  
W H Wright
Keyword(s):  
Transplant Patient ◽  
Cardiac Transplant ◽  
Portal Venous Gas ◽  
Cardiac Transplant Patient
Sign in / Sign up

Export Citation Format

Share Document